Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two bromelain preparations in an experimentally induced hematoma pain model
2005-002369-35Phase 3Completed
- Sponsor
- URSAPHARM
- Start
- May 2006
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain in hematoma and pain (2 arms), sponsored by URSAPHARM. Primary endpoint: Reduction of pain under pressure in the experimental hematoma model. Started May 2006; status: completed.
02
Drugs
bromelain
03
Conditions
hematomapain
Beyond the preview
Go deeper on 2005-002369-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002369-35.